Communicated by Mireille Claustres
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population†
Article first published online: 3 MAR 2009
© 2009 Wiley-Liss, Inc.
Volume 30, Issue 7, pages 1054–1061, July 2009
How to Cite
Nuytemans, K., Meeus, B., Crosiers, D., Brouwers, N., Goossens, D., Engelborghs, S., Pals, P., Pickut, B., Van den Broeck, M., Corsmit, E., Cras, P., De Deyn, P. P., Del-Favero, J., Van Broeckhoven, C. and Theuns, J. (2009), Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Hum. Mutat., 30: 1054–1061. doi: 10.1002/humu.21007
- Issue published online: 23 JUN 2009
- Article first published online: 3 MAR 2009
- Accepted manuscript online: 3 MAR 2009 12:00AM EST
- Manuscript Accepted: 4 FEB 2009
- Manuscript Received: 12 JUL 2008
- Parkinson disease;
The relative contribution of simple mutations and copy number variations (CNVs) in SNCA, PARK2, PINK1, PARK7, and LRRK2 to the genetic etiology of Parkinson disease (PD) is still unclear because most studies did not completely analyze each gene. In a large group of Belgian PD patients (N=310) and control individuals (N=270), we determined the mutation frequency of both simple mutations and CNVs in these five PD genes, using direct sequencing, multiplex amplicon quantification (MAQ), and real-time PCR assays. Overall, we identified 14 novel heterozygous variants, of which 11 were absent in control individuals. We observed eight PARK2 (multiple) exon multiplications in PD patients and one exon deletion in a control individual. Furthermore, we identified one SNCA whole-gene duplication. The PARK2 and LRRK2 mutation frequencies in Belgian PD patients were similar to those reported in other studies. However, at this stage the true pathogenic nature of some heterozygous mutations in recessive genes remains elusive. Furthermore, though mutations is SNCA, PINK1, and PARK7 are rare, our identification of a SNCA duplication confirmed that screening of these genes remains meaningful. Hum Mutat 30:1–8, 2009. © 2009 Wiley-Liss, Inc.